Adjuvant chemotherapy of pT1a and pT1b breast carcinoma
BMC Cancer, 05/02/2012Gori S et al.
Adjuvant chemotherapy was delivered in 31.59% T1a–pT1b BC treated at 63 Italian oncological centres from January 2008 to June 2008. The choice to deliver chemotherapy was based on biological prognostic factors. Anthracycline–based chemotherapy was administered in 83.5% patients.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.